News | Heart Valve Technology
October 2, 2019 – The Abbott Portico FDA investigational device exemption (IDE) study found that 30-day safety and one ...
October 02, 2019
News | Cath Lab | Dave Fornell, Editor
October 2, 2019 — Democratic presidential candidate Sen. Bernie Sanders (D-VT) was hospitalized with chest pain on Oct ...
October 02, 2019
October 2, 2019 — Philips Healthcare is utilizing Level Ex’s video game app design expertise to train interventional ...
October 02, 2019Sponsored Content
Feature | Information Technology
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
March 21, 2024
360 Photos | 360 View Photos
This 360 degree view shows staff at the University of Colorado Heart and Vascular Center performing live transesophageal ...
October 02, 2019
I recently had the opportunity to conduct an onsite visit to the University of Colorado Hospital Heart and Vascular ...
October 02, 2019
Feature | Dave Fornell, Editor
October 1, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...
October 01, 2019Sponsored Content
Feature | Cardiac Imaging
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
March 05, 2024
Feature | Henry Ford Hospital | Dave Fornell, Editor
Henry Ford Hospital thought leaders regularly speak at the cardiology conferences about new research and technology ...
October 01, 2019
Videos | Heart Valve Technology
Marvin Eng, M.D., structural fellowship director at Henry Ford Health System, and William O'Neill, M.D., director of the ...
September 30, 2019
News | Stents Drug Eluting
The first randomized trial to compare a durable polymer drug- eluting stent to a polymer-free drug-coated stent in patients at high risk of bleeding and treated with one-month dual antiplatelet therapy (DAPT) found that both are clinically safe and effective.
September 30, 2019Sponsored Content
Blog
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
December 11, 2023
News | Stents Drug Eluting
A biodegradable polymer everolimus-eluting stent (BP-EES) followed by four months of dual antiplatelet therapy (DAPT) is safe and effective in patients undergoing percutaneous coronary intervention (PCI) for unprotected left main coronary artery (uLMCA) disease. These findings are courtesy of the IDEAL-LM trial, which compared BP-EES plus four months of DAPT to a conventional durable polymer everolimus-eluting stent (DP-EES) followed by 12 months of DAPT.
September 30, 2019
Videos | Structural Heart
A discussion with William O’Neill, M.D., director of the Henry Ford structural heart program, Ruth Fisher, MBA, vice ...
September 30, 2019
Data from the EVOLVE Short DAPT study found that shortened three-month dual antiplatelet therapy (DAPT) did not increase myocardial infarction (MI) or stent thrombosis (ST) in high bleeding risk (HBR) patients treated with a contemporary drug-eluting stent.
September 30, 2019Sponsored Content
Case Study | Hemodynamic Monitoring Systems
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
November 14, 2023
Videos | Cardiovascular Business
A discussion with Ruth Fisher, MBA, vice president of the Henry Ford Hospital structural heart program, and Janet Wyman ...
September 30, 2019
Videos | Cath Lab
A discussion with Nicolas Bevins, Ph.D., vice chair, physics and research, and Jessica Harrington, RCIS. They explain ...
September 28, 2019
Videos | Chronic Total Occlusion (CTO)
A discussion with Khaldoon Alaswad, M.D., director, cardiac catheterization lab, Henry Ford Hospital, on treating ...
September 28, 2019© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now